Leprosy

Genetic diversity: GSK and Novartis launch Project Africa GRADIENT to optimise treatment responses for malaria and tuberculosis in Africa

Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria…

3 years ago

World Leprosy Day 2016: Novartis Foundation renews its commitment to fight leprosy

2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this…

8 years ago

Novartis Foundation for Sustainable Development (NFSD) launched new leprosy strategy focused on interrupting leprosy transmission through early diagnosis and treatment

Experts present lessons learned from past control programs and new approaches to eliminating diseases such as leprosy and malaria. The Novartis…

10 years ago

University of Tübingen scientists reconstructed medieval leprosy genomes to shed light on disease’s history

27-6-2013 — /europawire.eu/ — An international team of scientists reconstructed a dozen medieval and modern leprosy genomes – suggesting a European…

11 years ago